Otsuka DNS Flexidrip Injection
Marketer
Otsuka Pharmaceuticals Pvt Ltd
Salt Composition
Dextrose (5% w/v) + Sodium Chloride (0.9% w/v)
Overview Otsuka DNS Flexidrip Injection
Otsuka DNS Flexidrip Injection is a short-term fluid replacement therapy for post-trauma hypovolemia. Its mechanism of action involves replenishing plasma volume lost from significant hemorrhage. Administration is strictly intravenous, under medical guidance. Dosage is individualized, based on the indication and clinical severity. Treatment duration is determined by the prescribing physician. Strict adherence to the doctor's instructions is crucial. This medication generally exhibits a favorable safety profile with minimal reported side effects. Prior to initiating treatment, inform your physician of any pre-existing conditions such as diabetes or kidney impairment. Disclosure of pregnancy or lactation is also mandatory. Complete disclosure of all concurrent medications is essential, as interactions affecting efficacy and safety are possible.
Primary Ingredients of Otsuka DNS Flexidrip Injection
No text was provided to rewrite.
Uses of Otsuka DNS Flexidrip Injection
Post-trauma hydration management
Major Benefits of Otsuka DNS Flexidrip Injection:
This medication will be administered by your healthcare provider. Self-medication is strongly discouraged.
Common Side effects of Otsuka DNS Flexidrip Injection:
- No common side effects seen
How to use Otsuka DNS Flexidrip Injection:
This medication will be administered by your healthcare provider; self-medication is strictly prohibited.
How Otsuka DNS Flexidrip Injection works:
Otsuka's Flexidrip injection, containing dextrose and sodium chloride, replenishes blood plasma depleted by significant hemorrhage. This is crucial because plasma is essential for circulating oxygen-carrying red blood cells.
SAFETY ADVICE
AlcoholCONSULT YOUR DOCTOR
The safety of combining alcohol with Otsuka DNS Flexidrip Injection is unestablished. Seek medical advice before mixing them.
PregnancyCONSULT YOUR DOCTOR
Administering Otsuka DNS Flexidrip Injection during pregnancy may pose risks. While human research is scant, animal studies indicate potential harm to the fetus. A physician will assess the advantages against possible risks prior to prescription. Seek medical advice.
Breast feedingCONSULT YOUR DOCTOR
Data on the compatibility of Otsuka DNS Flexidrip Injection with breastfeeding is currently unavailable. Seek medical advice from your physician.
DrivingCONSULT YOUR DOCTOR
The effect of Otsuka DNS Flexidrip Injection on driving ability is unknown. Refrain from driving if experiencing symptoms impairing concentration or reaction time.
KidneyUNSAFE
The use of Otsuka DNS Flexidrip Injection is potentially hazardous for individuals with kidney disorders and should be avoided. Medical advice from a physician is recommended. Patients exhibiting renal dysfunction require careful monitoring.
LiverSAFE IF PRESCRIBED
The use of Otsuka DNS Flexidrip Injection in individuals with liver impairment appears to pose minimal risk. Current evidence indicates dose modification may be unnecessary, but physician consultation is recommended.
What if you forget to take Otsuka DNS Flexidrip Injection :
NA
Facts to Know About Otsuka DNS Flexidrip Injection
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | KINSHIP |
3,018 People bought this recently